or Try an Advanced Search...

    Hepatitis B Virus Stocks List

    Symbol Grade Name % Change
    ABUS B Arbutus Biopharma Corporation 0.96
    IONS B Ionis Pharmaceuticals, Inc. 1.02
    INO D Inovio Pharmaceuticals, Inc. -1.19
    NNVC D NanoViricides, Inc. -1.12
    HOOK F HOOKIPA Pharma Inc. -0.43
    NTLA F Intellia Therapeutics, Inc. 3.61
    VIR F Vir Biotechnology, Inc. -1.02
    BMY F Bristol-Myers Squibb Company -0.96
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 9.55
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 6.5
    GNOM D Global X Genomics & Biotechnology ETF 5.57
    PPH B Market Vectors Pharmaceutical ETF 4.49
    IHE B iShares U.S. Pharmaceutical ETF 4.4
    View all Hepatitis B Virus ETFs...
    Compare ETFs
    Compare ARKG to PPH Compare FTXH to GNOM Compare FTXH to IHE

        Hepatitis B Virus Stocks Recent News

        Date Stock Title
        Jul 3 NTLA Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
        Jul 2 INO INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
        Jul 2 NTLA 3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024
        Jul 2 HOOK HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial
        Jul 2 BMY Eisai and Bristol Myers Squibb terminate ADC development deal
        Jul 1 HOOK HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
        Jul 1 BMY Eisai receives rights to antibody drug conjugate after Bristol ends collaboration
        Jul 1 BMY What the Options Market Tells Us About Bristol-Myers Squibb
        Jul 1 BMY Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says
        Jul 1 INO Inovio Pharmaceuticals added to Russell 2000 index effective July 1
        Jul 1 BMY Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
        Jul 1 INO INOVIO Added to Russell 2000® Index Effective July 1, 2024
        Jul 1 BMY Eisai and Bristol Myers cancel cancer ADC deal
        Jun 28 BMY Bristol-Myers Squibb: Time To Double Down
        Jun 27 BMY Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
        Jun 27 BMY You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
        Jun 27 NTLA Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
        Jun 27 NTLA Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
        Jun 27 NTLA Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection
        Hepatitis B Virus

        Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

        More about Hepatitis B Virus
        Browse All Tags